Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

DRRX Durect Corp

Price (delayed)

$0.6301

Market cap

$19.56M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.15

Enterprise value

$13.58M

DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic ...

Highlights
The debt has dropped by 89% year-on-year and by 10% since the previous quarter
The EPS has soared by 82% year-on-year and by 44% since the previous quarter
The company's quick ratio fell by 30% QoQ but it rose by 23% YoY
The revenue has dropped by 74% since the previous quarter and by 49% year-on-year
Durect's gross profit has shrunk by 62% QoQ and by 36% YoY

Key stats

What are the main financial stats of DRRX
Market
Shares outstanding
31.04M
Market cap
$19.56M
Enterprise value
$13.58M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.66
Price to sales (P/S)
37.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
25.87
Earnings
Revenue
$525,000
Gross profit
$736,000
Operating income
-$17.33M
Net income
-$4.91M
EBIT
-$5.44M
EBITDA
-$5.34M
Free cash flow
-$15.87M
Per share
EPS
-$0.15
EPS diluted
-$0.15
Free cash flow per share
-$0.51
Book value per share
$0.17
Revenue per share
$0.02
TBVPS
$0.37
Balance sheet
Total assets
$14.36M
Total liabilities
$9.01M
Debt
$1.98M
Equity
$5.35M
Working capital
$1.74M
Liquidity
Debt to equity
0.37
Current ratio
1.23
Quick ratio
1.12
Net debt/EBITDA
1.12
Margins
EBITDA margin
-1,017.1%
Gross margin
140.2%
Net margin
-935.8%
Operating margin
-3,301.7%
Efficiency
Return on assets
-22.7%
Return on equity
-94.8%
Return on invested capital
-1,352%
Return on capital employed
-81.4%
Return on sales
-1,036.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DRRX stock price

How has the Durect stock price performed over time
Intraday
2.02%
1 week
-13.68%
1 month
-12.49%
1 year
-33.24%
YTD
-15.99%
QTD
-21.43%

Financial performance

How have Durect's revenue and profit performed over time
Revenue
$525,000
Gross profit
$736,000
Operating income
-$17.33M
Net income
-$4.91M
Gross margin
140.2%
Net margin
-935.8%
The net margin has dropped by 128% since the previous quarter but it has surged by 59% year-on-year
The net income has soared by 79% YoY and by 41% from the previous quarter
The revenue has dropped by 74% since the previous quarter and by 49% year-on-year
Durect's gross profit has shrunk by 62% QoQ and by 36% YoY

Price vs fundamentals

How does DRRX's price correlate with its fundamentals

Growth

What is Durect's growth rate over time

Valuation

What is Durect stock price valuation
P/E
N/A
P/B
3.66
P/S
37.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
25.87
The EPS has soared by 82% year-on-year and by 44% since the previous quarter
DRRX's P/B is 70% below its last 4 quarters average of 12.3 and 52% below its 5-year quarterly average of 7.7
Durect's equity has decreased by 41% from the previous quarter and by 36% YoY
The price to sales (P/S) is 109% higher than the 5-year quarterly average of 17.8 and 18% higher than the last 4 quarters average of 31.6
The revenue has dropped by 74% since the previous quarter and by 49% year-on-year

Efficiency

How efficient is Durect business performance
The ROS has dropped by 153% since the previous quarter but it has soared by 55% year-on-year
Durect's ROE has soared by 56% YoY and by 33% from the previous quarter
Durect's ROA has soared by 55% YoY and by 26% from the previous quarter

Dividends

What is DRRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DRRX.

Financial health

How did Durect financials performed over time
The total assets is 59% more than the total liabilities
DRRX's total liabilities has shrunk by 68% YoY and by 2.3% QoQ
The total assets has plunged by 60% YoY and by 22% from the previous quarter
The debt is 63% smaller than the equity
The debt has dropped by 89% year-on-year and by 10% since the previous quarter
The debt to equity has dropped by 83% year-on-year but it has soared by 54% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.